Biomarker Lens

Biomarkers · Chemical

Risankizumab Drug

Understand what Risankizumab Drug signals

Primary unit
ug/mL
LOINC codes
105194-5
Commercial laboratory assays
1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Risankizumab Drug

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Risankizumab and Anti-Risankizumab Antibody, Dose ASSURE™ RSK

Laboratory
Labcorp
Test code
505895
Specimen
Serum
Fasting
Not stated
LOINC
105194-5
Turnaround
14 days

Laboratory assay overview

This test is used for quantification of risankizumab drug ( μ g/mL) and risankizumab anti-drug antibodies (ng/mL) in patients treated with risankizumab for ulcerative colitis, Crohn's disease, plaque psoriasis and psoriatic arthritis.

Labcorp test directory, test code 505895

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.